ReviewMolecular therapy oncolytics2023

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies.

Ying Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.